Director, Imaging Biomarkers

Dyne Therapeutics(8 days ago)

Waltham, MAOnsiteFull TimeDirector$196,000 - $240,000Clinical Development

About this role

Dyne Therapeutics is a biotechnology company developing therapeutics for genetically driven neuromuscular diseases targeting muscle and the CNS. The Director of Imaging Biomarkers will lead the development and execution of imaging biomarker strategies across preclinical and clinical programs to inform disease understanding, assess therapeutic efficacy, and support regulatory submissions. Based in Waltham, MA, the role provides scientific leadership to translate early-phase research into clinical development and decision making.

View Original Listing

Required Skills

Imaging Biomarkers
MRI
PET
CT
Ultrasound
Image Analysis
Quantitative Imaging
Regulatory Affairs
Clinical Trials
Project Management

+4 more

Qualifications

Ph.D. (Biomedical Engineering, Medical Physics, Radiology or related)
M.D.

About Dyne Therapeutics

dyne-tx.com

Dyne Therapeutics is a biotechnology company developing nucleic acid–based therapies for rare, inherited muscle diseases. With the mission "Repairing muscle, reclaiming now," it aims to create life‑transforming medicines that restore muscle function and improve patients' lives. Dyne advances programs from discovery into clinical development with a focus on genetic muscle disorders (including various muscular dystrophies) and works with partners to accelerate delivery of therapies to patients.